Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug

Frontiers in Microbiology
Giorgia MoriMaria Rosalia Pasca

Abstract

Tuberculosis remains one of the leading causes of death from a single pathogen globally. It is estimated that 1/4 of the world's population harbors latent tuberculosis, but only a 5-10% of patients will develop active disease. During latent infection, Mycobacterium tuberculosis can persist unaffected by drugs for years in a non-replicating state with low metabolic activity. The rate of the successful tuberculosis treatment is curbed by the presence of these non-replicating bacilli that can resuscitate after decades and also by the spread of M. tuberculosis drug-resistant strains. International agencies, including the World Health Organization, urge the international community to combat this global health emergency. The thienopyrimidine TP053 is a promising new antitubercular lead compound highly active against both replicating and non-replicating M. tuberculosis cells, with an in vitro MIC of 0.125 μg/ml. TP053 is a prodrug activated by the reduced form of the mycothiol-dependent reductase Mrx2, encoded by Rv2466c gene. After its activation, TP053 releases nitric oxide and a highly reactive metabolite, explaining its activity also against M. tuberculosis non-replicating cells. In this work, a new mechanism of TP053 resistance w...Continue Reading

References

Mar 28, 2002·Nucleic Acids Research·Vivek AnantharamanL Aravind
Sep 4, 2003·The Journal of Experimental Medicine·Martin I VoskuilGary K Schoolnik
Mar 29, 2008·Methods in Molecular Biology·Julia C van Kessel, Graham F Hatfull
Jul 31, 2009·Communicative & Integrative Biology·Ujjini ManjunathaClifton E Barry
Sep 17, 2015·The New England Journal of Medicine·Haileyesus GetahunMario Raviglione
Sep 17, 2015·The New England Journal of Medicine·Jennifer FloodRobert Belknap
Nov 8, 2015·The Journal of Biological Chemistry·David Albesa-JovéMarcelo E Guerin
Dec 3, 2016·Nucleic Acids Research·Aron Marchler-BauerStephen H Bryant
Jun 10, 2018·Current Opinion in Pharmacology·Anastasia KochValerie Mizrahi
Nov 16, 2019·ACS Infectious Diseases·Laurent R ChiarelliMaria Rosalia Pasca
Nov 17, 2019·Clinics in Chest Medicine·Moises A Huaman, Timothy R Sterling

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
RNA-seq

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.